Prognostic role of homeostasis model assessment and oral glucose tolerance test in nondiabetic patients with Bell’s palsy

Background/aim: We aimed to reveal the incidence and predictive role of insulin resistance and distorted oral glucose tolerance test innondiabetic patients with Bell’s Palsy (BP).Materials and methods: Eighty-six patients with BP and 28 control subjects; all with normal blood glucose levels and no history ofdiabetes, were enrolled in the study. We investigated insulin resistance (IR) in all subjects, in terms of HOMA-IR greater than 2.7. Sixtytwoof the patients also underwent an oral glucose tolerance test (OGTT).Results: The mean HOMA-IR value was significantly increased in patients, compared to the control group (3.2 vs 1.6; P < 0.01). IR wasdetected more in BP patients than in controls (P < 0.05). The patients with higher HOMA-IR values had more severe facial dysfunctionat the initial presentation and complete recovery time took longer than the patients with normal HOMA-IR value (75 days vs 42 days; P< 0.05). Following a 2h-OGTT, impaired glucose tolerance and newly diagnosed DM were found in 60% of the patients. Recovery timewas significantly longer in prediabetics and newly diagnosed diabetic patients than in patients with normal glycemia (68 days, 52 days,and 32 days, respectively; P < 0.01).Conclusion: There is a strong linkage between HOMA-IR value and BP prognosis so HOMA-IR value may have a significant role ofpredicting BP prognosis at presentation.

PDF

___

1. Akyıldız N. Periferik Fasiyal Paraliziler ve Cerrahi Tedavisi. In: Akyıldız N (eds). Kulak Hastalıkları ve Mikrocerrahisi. 2.Cilt. Ankara, Türkiye: Bilimsel Tıp; 2002. pp.560-580 (in Turkish).
2. Mattox DE. Clinical Disorders of the Facial Nerve. In: Flint PW, Haughey BH, Lund VJ, Niparko JK, Robbins KT, Thomas JR, Lesperance MM (eds). Cummings Otolaryngology: Head- Neck Surgery. 6th edition. Philadelphia, USA: Mosby Elsevier; 2015. pp. 2617-2628.
3. Maloney WJ. Bell’s palsy: the answer to the riddle of Leonardo da Vinci’s ‘Mona Lisa’. Journal of Dental Research 2011;90 (5): 580-582. doi: 10.1177/0022034510384629
4. Peitersen E. Bell’s Palsy: The spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Oto-Laryngologica 2002; 122 (7): 4-30. doi: 10.1080/000164802760370736
5. Gilden DH. Clinical practice. Bell’s palsy. The New England Journal of Medicine 2004; 351: 1323–1331.
6. Riga M, Kefalidis G, and Danielides V. The role of diabetes mellitus in the clinical presentation and prognosis of Bell palsy. Journal of the American Board of Family Medicine 2012; 25(6): 819-826. doi: 10.3122/jabfm.2012.06.120084
7. Vinik A, Mitchell B. Clinical aspects of diabetic neuropaties. Diabetes Metabolism Reviews 1988;4 (3): 223-253. doi: 10.1002/dmr.5610040304
8. Smith AG, Singleton JR. Impaired glucose tolerance and peripheral neuropathy. Neurologist 2008; 14: 24-29. doi: 10.1097/NRL.0b013e31815a3956
9. Smith AG, Singleton JR. The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy. Archives of Internal Medicine 2004; 164: 1021-1025. doi: 10.1001/archinte.164.9.1021
10. Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 2006; 29 (6): 1294-1299. doi: 10.2337/dc06-0224
11. Bosco D, Plastino M, Bosco F, Consoli A, Labate A et al. Bell’s palsy: a manifestation of prediabetes? Acta Neurologica Scandinavica 2011; 123 (1): 68-72. doi: 10.1111/j.1600- 0404.2010.01365.x
12. Buysschaert M, Bergman M. Definition of prediabetes. Medical Clinics of North America 2011; 95 (2): 289-297. doi: 10.1016/j. mcna.2010.11.002
13. Kim B, Feldman EL. Insulin resistance in the nervous system. Trends Endocrinology Metabolism 2012; 23 (3): 133-141. doi: 10.1016/j.tem.2011.12.004
14. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet 2004; 363 (9403): 157-163. doi: 10.1016/S0140-6736(03)15268-3
15. Hatun Ş. Çocukluk çağında obezite ve insulin rezistansı. Turkish Journal of Endocrinology and Metabolism. 2003; 7(2): 23-26 (in Turkish).
16. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 1998; 15 (7): 539- 553. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AIDDIA668> 3.0.CO;2-S
17. Engström M, Berg T, Stjernquist-Desatnik A, Axelsson S, Pitkäranta A et al. Prednisolone and valaciclovir in Bell’s palsy: a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet Neurology 2008; 7(11): 993-1000. doi: 10.1016/S1474-4422(08)70221-7
18. Schwaber MK, Larson TC 3rd., Zealear DL, Creasy J. Gadolinium-enhanced magnetic resonance imaging in Bell’s palsy. Laryngoscope 1990;100: 1264-1269.
19. Tien R, Dillon WP, Jackler RK. Contrast-enhanced MR imaging of the facial nerve in 11 patients with Bell’s palsy. American Journal of Roentgenology 1990;155(3): 573-579. doi. 10.2214/ ajr.155.3.2117359
20. Adour KK, Wingerd J, Doty HE. Prevalence of concurrent diabetes mellitus and idiopathic facial paralysis (Bell’s palsy). Diabetes 1975; 24(5): 449-451. doi: 10.2337/diab.24.5.449
21. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001; 24(8): 1448-1453. doi: 10.2337/diacare.24.8.1448
22 Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: where are we now and where to go? Journal of Diabetes Investigation 2011; 2(1): 18-32. doi: 10.1111/j.2040- 1124.2010.00070.x
23. Putz Z, Tabák AG, Tóth N, Istenes I, Németh N et al. Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care 2009; 32(1):181- 183. doi: 10.2337/dc08-1406
24. Esaki S, Yamano K, Kiguchi J, Katsumi S, Keceli S et al. Diabetic mice show an aggravated course of herpes-simplex virusinduced facial nerve paralysis. Otology & Neurotology 2012; 33(8): 1452-1457. doi: 10.1097/MAO.0b013e318268d54d
25. Sittel C, Sittel A, Guntinas-Lichius O, Eckel HE, Stennert E. Bell’s palsy: a 10-year experience with antiphlogisticrheologic infusion therapy. American Journal of Otolaryngology 2000; 21(3): 425-432. doi: 10.1016/s0196-0709(00)80055-1
26. Pleiner J, Schaller G, Mittermayer F, Bayerle-Eder M, Roden M et al. FFA-induced endothelial dysfunction can be corrected by vitamin C. The Journal of Clinical Endocrinology and Metabolism 2002; 87(6): 2913-2917. doi: 10.1210/ jcem.87.6.8596
27. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiology of Disease 1999; 6(5): 347-363. doi: 10.1006/nbdi.1999.0254
28. Jonkers IJ, van de Ree MA, Smelt AH, de Man FH, Jansen H et al. Insulin resistance but not hypertriglyceridemia per se is associated with endothelial dysfunction in chronic hypertriglyceridemia. Cardiovascular Research 2002; 53(2): 496-501. doi: 10.1016/s0008-6363(01)00504-1
29. Boyanovsky B, Karakashian A, King K, Giltiay N, Nikolova- Karakashian M. Uptake and metabolism of low density lipoproteins with elevated ceramide content by human microvascular endothelial cells: implications for the regulation of apoptosis. Journal of Biological Chemistry 2003; 278(29): 26992-26999. doi: 10.1074/jbc.M301536200
30. Kanazawa A, Haginomori S, Takamaki A, Nonaka R, Araki M et al. Prognosis for Bell’s palsy: a comparison of diabetic and nondiabetic patients. Acta Oto-Laryngologica 2007; 127(8): 888-891. doi: 10.1080/00016480601075399
31. Feldman EL, Russell JW, Sullivan KA, Golovoy D. New insights into the pathogenesis of diabetic neuropathy. Current Opinion in Neurology 1999; 12(5): 553-563. doi: 10.1097/00019052- 199910000-00009